Supplementary Table S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

Autoría

autor: Timothy Cloughesy, Yue Hao, Louis B Nabors, Lisa Rogers, Andrew Sloan, Michael E Berens, Jan Drappatz, Matthias Holdhoff, Manmeet S Ahluwalia, David M Peereboom, Ahmad Ozair, Tobias Walbert, Marta Couce, Patrick Yung Wen